“Cannabis is not harmless: it can increase psychosis risk, with potentially significant risk in vulnerable individuals, and schizophrenia has genetic, developmental, environmental, and other contributors.”
@psychologywithankitaReel analyzed by Clear
“Natural hona harmless hone ki guarantee nahi—risk context matters.”
The post correctly distinguishes psychosis from a single-cause explanation of schizophrenia and accurately says cannabis can raise psychosis risk. Evidence indicates stronger associations with early initiation and more frequent or heavy use.
The opening question could be read as implying that cannabis straightforwardly causes schizophrenia. The evidence supports elevated risk and possible contribution, not a deterministic outcome or a diagnosis from symptoms alone.
Not material. The slide itself adds the key context that schizophrenia involves genetics, brain development, environment, and other risk factors, and frames cannabis as increasing risk rather than guaranteeing illness.
Why Clear says this
WHO, CDC, and evidence reviews report an association between cannabis use and psychosis or schizophrenia, with risk tending to be greater with earlier and heavier use. Causation at the individual level remains difficult to establish because vulnerability and other factors also matter.
Evidence
- WHO states that schizophrenia has no single identified cause and that heavy cannabis use is associated with elevated risk.
- CDC states cannabis users are more likely to develop psychosis and schizophrenia, with a stronger association for earlier and more frequent use.
- A WHO expert review reports dose-dependent population-level links, while noting that most users do not develop psychotic disorders and genetic vulnerability likely contributes.